Market Tracker

07/31 5:09am ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

21.75
Delayed Data
As of Jul 30
 -0.21 / -0.96%
Today’s Change
9.38
Today|||52-Week Range
25.56
+80.65%
Year-to-Date

Today’s Trading

Previous close21.96
Today’s open21.80
Day’s range-- - --
Volume536,300
Average volume (3 months)959,602
Market cap$1.4B
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+10.33%
Earnings growth (this year)+61.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+47.33%
P/E ratioNM
Price/Sales11.91
Price/Book5.80

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.26-1.75%
MCRBSeres Therapeutics I...+0.41+1.09%
RLYPRelypsa Inc-0.34-1.00%
ESPREsperion Therapeutic...+1.77+2.83%
Data as of 07/30/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$52.3M
Annual profit (last year)-$98.6M
Net profit margin-188.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Richard P. Shea
Corporate headquarters
Cambridge, Massachusetts

Forecasts